GV 2017, L.P. 13D/13G Filings for TScan Therapeutics, Inc. (TCRX)

GV 2017, L.P. 13D and 13G filings for TScan Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-09
4:08 pm
Unchanged		 2023-12-31 13G TScan Therapeutics, Inc.
TCRX		 GV 2017, L.P. 1,077,080
2.500%		 0
(Unchanged)		 Filing
2022-02-14
11:39 am
Purchase		 2021-12-31 13G TScan Therapeutics, Inc.
TCRX		 GV 2017, L.P. 1,077,080
5.780%		 1,077,080increase
(New Position)		 Filing